Healthcare -
Biotechnology - NASDAQ - US
$ 54.8
-1.03 %
$ 6.97 B
Market Cap
18.15
P/E
HALO - RESEARCH & DEVELOPMENT
Research & Development HALO - Halozyme Therapeutics, Inc.
76.4 M
LAST VALUE
46.31%
2 YEAR CAGR
-12.66%
5 YEAR CAGR
-2.33%
10 YEAR CAGR